Abstract
The sulfoxide of chlorpromazine has been shown to be a relatively weak and short-acting sedative agent in man. Evidence is presented that this metabolite of chlorpromazine does not contribute significantly to the action of the parent compound.
Footnotes
- Received March 7, 1957.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement